Overview Fundamentals Financials Technicals Corporate Action Shareholding Pattern Peer Comparison News Stock Analysis About Company FAQs

Bafna Pharmaceuticals Ltd Share Price

Pharmaceuticals - Indian - Formulations

NSE: BAFNAPH Small Cap ISIN: INE878I01022
As on 12 February 2025 at 02:36 IST
As on 12 February 2025 at 02:36 IST
77.90
-0.26
(-0.33%)
Over 1 Month
-5.96%
Over 6 Months
-3.99%
Over 1 Year
-19.11%
Over 3 Years
-54.98%

Bafna Pharmaceuticals Ltd Summary

Close ₹ 77.90
Open ₹ 78.11
High ₹ 81.49
Low ₹ 76
Volume 1,958
Net Turnover (in ₹ Cr) ₹ 0.015
52Wk High ₹ 113
52Wk Low ₹ 73.25
52Wk High / Low
73.25
113

Bafna Pharmaceuticals Ltd Fundamentals

Key Financial Data

Market Cap (in ₹Cr) ₹ 184.28
EPS (TTM) 1.97
Book Value (BV) 34.98
Div. Yield -
P/E (TTM) 41.26
Price/Book Value 2.15
Delivery % -
Face Value 10

Key Ratios

PE Ratio 24.65
PB Ratio 2.24
EV to Sales 1.34
PEG Ratio -0.70
ROA 6.85
ROE 5.74
Debt-Equity 0.31
Net Profit Margin 4.82
Operating Profit Margin 9.60

Bafna Pharmaceuticals Ltd Financials

Profit and Loss

Particulars (in ₹ Cr.) FY 2020FY 2019FY 2018FY 2017FY 2016
Total Revenue42.7344.0178.5066.1087.30
Total Expenses44.6162.3193.2286.46102.62
Profit Before Tax-1.88-18.29-14.72-20.36-15.32
Profit After Tax-1.88-19.36-16.91-19.46-15.14
Operating Profit after Depreciation-1.79-16.17-7.77-8.89-2.36

Balance Sheet

Particulars (in ₹ Cr.) FY 2020FY 2019FY 2018FY 2017FY 2016
Fixed Assets3537.0544.9048.6152.61
Total Non Current Assets35.227189.62101.1270.22
Total Current Assets36.1048.4748.7477.18122.48
TOTAL ASSETS71.31119.47138.36178.31192.71
Total Shareholder's Fund51.1119.0637.9342.6757.75

Cash Flow

Particulars (in ₹ Cr.) FY 2020FY 2019FY 2018FY 2017FY 2016
Net Cash from Operating Activities-34.31-1.79-7.05-0.950.91
Net Cash used in Investing Activities32.7715.3637.97-5.42-0.36
Net Cash used in Financing Activities7.30-13.81-30.636.31-0.61

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Total Revenue155.99118.6286.8471.9742.73
Total Expenses148.64107.0179.4766.1444.61
Profit Before Tax7.3511.625.225.83-1.88
Profit After Tax7.3511.345.225.83-1.88
Operating Profit after Depreciation9.6413.658.176.57-1.78

Balance Sheet

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Fixed Assets41.9841.7338.8535.9734.97
Total Non Current Assets53.2142.2739.2636.8035.18
Total Current Assets94.4787.3150.8849.6735.88
TOTAL ASSETS147.68129.5890.1486.4771.06
Total Shareholder's Fund80.8473.4561.9656.7750.95

Cash Flow

Particulars (in ₹ Cr.) FY 2024FY 2023FY 2022FY 2021FY 2020
Net Cash from Operating Activities9.484.959.73-13.61-34.27
Net Cash used in Investing Activities-15.05-7.49-6.54-5.3532.78
Net Cash used in Financing Activities-0.8510.18-4.8112.287.27

Particulars (in ₹ Cr.) 2019-09 2019-06 2018-09 2018-06
Total Revenue11.576.858.84-
Total Expenses11.949.718.66-
Profit Before Tax-0.54-3.71-1.22-
Profit After Tax-0.59-2.13-1.28-3.52
Operating Profit after Depreciation0.22-2.560.15-

Particulars (in ₹ Cr.) 2024-12 2024-09 2024-06 2024-03 2023-12
Total Revenue33.1940.3233.2941.4028.44
Total Expenses30.1236.5332.0838.5130.52
Profit Before Tax0.952.61-0.721.46-2.95
Profit After Tax0.952.62-0.721.46-2.94
Operating Profit after Depreciation3.264.811.723.41-1.10

Bafna Pharmaceuticals Ltd Technicals

Support and Resistance

S3 S2 S1 Pivot R1 R2 R3
S1 76.44
S2 74.72
S3 71.44
Pivot 79.72
R1 81.44
R2 84.72
R3 86.44

Moving Average

20 SMA 80.16
50 SMA 80.81
100 SMA 80.90
200 SMA 83.07

Bafna Pharmaceuticals Ltd Corporate Actions

No available data

Bafna Pharmaceuticals Ltd Peer Comparison

Company Price Market Cap (in ₹ Cr)
Bafna Pharmaceuticals Ltd ₹75.10 ₹177.66
Sun Pharmaceuticals Industries Ltd ₹1,699.75 ₹4,07,826.96
Divis Laboratories Ltd ₹5,949.15 ₹1,57,931.24
Cipla Ltd ₹1,452.70 ₹1,17,322.09
Torrent Pharmaceuticals Ltd ₹3,104.95 ₹1,05,080.90
Mankind Pharma Ltd ₹2,451.35 ₹1,01,134.59

Bafna Pharmaceuticals Ltd News

Bafna Pharmaceuticals announces board meeting date

On 6 February 2025

28 Jan 2025, 05:34 pm

Bafna Pharmaceuticals to discuss results

On 11 November 2024

04 Nov 2024, 06:39 pm

Bafna Pharmaceuticals schedules AGM

On 25 September 2024

05 Sep 2024, 10:29 am

Bafna Pharmaceuticals to convene AGM

On 25 September 2024

04 Sep 2024, 05:49 pm

Bafna Pharmaceuticals to declare Quarterly Result

On 13 August 2024

10 Aug 2024, 01:56 pm

Bafna Pharmaceuticals Ltd Stock Analysis

  1. Annual revenue for Bafna Pharmaceuticals Ltd increased by 31.50% to ₹155.99 crore in FY 2024 from ₹118.62 crore in FY 2023.
  2. Annual Net Profit for Bafna Pharmaceuticals Ltd decreased by 35.19% to ₹7.35 crore in FY 2024 from ₹11.34 crore in FY 2023.
  3. Promoter Shareholding in Bafna Pharmaceuticals Ltd remains unchanged by 0.00% in the most recent quarter, from 88.30% in September 2024 to 88.30% in December 2024.
  4. Bafna Pharmaceuticals Ltd delivered a 1-year return of -19.11% compared to the Nifty 50, which provided a return of 6.73% as of the last trading session.
  5. Bafna Pharmaceuticals Ltd share price moved down by 0.33% from its previous close of INR ₹78.16. The latest Bafna Pharmaceuticals Ltd share price is INR ₹77.90.
  6. Bafna Pharmaceuticals Ltd share price today has been at a low of 76 and a high of 81.49. Over the past 52 weeks, the Bafna Pharmaceuticals Ltd share price has seen a low of 73.25 and a high of 113.

FAQ’s

What is the share price of Bafna Pharmaceuticals Ltd today?

Bafna Pharmaceuticals Ltd share price as on 11 Feb 2025 is ₹ 77.9

What is the Market Cap of Bafna Pharmaceuticals Ltd?

The market cap of Bafna Pharmaceuticals Ltd stock is ₹184.28 Cr.

What is the PE Ratio of Bafna Pharmaceuticals Ltd?

The Price to Earnings (P/E) Ratio of Bafna Pharmaceuticals Ltd is 24.65

What is the PB Ratio of Bafna Pharmaceuticals Ltd?

The Price to Book (P/B) Ratio of Bafna Pharmaceuticals Ltd is 2.24

What is the 52 week high of Bafna Pharmaceuticals Ltd Share Price?

The 52 week high of Bafna Pharmaceuticals Ltd share price stands at ₹113

What is the 52 week low of Bafna Pharmaceuticals Ltd Share Price?

The 52 week low of Bafna Pharmaceuticals Ltd share price stands at ₹73.25

Get started with us today and
start building your wealth journey